Construction and Validation of a Potent Epigenetic Modification-Related Prognostic Signature for Osteosarcoma Patients

Figure 3

KEGG pathway and GO enrichment analysis of aberrantly expressed EMGs. (a) Upregulated EMGs. (b) Downregulated EMGs.

(a)

(b)